nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—SHBG—hypothyroidism	0.729	1	CbGaD
Levonorgestrel—PGR—corpus luteum—hypothyroidism	0.014	0.126	CbGeAlD
Levonorgestrel—SHBG—seminiferous tubule of testis—hypothyroidism	0.0132	0.118	CbGeAlD
Levonorgestrel—CYP19A1—corpus luteum—hypothyroidism	0.0126	0.113	CbGeAlD
Levonorgestrel—CYP19A1—seminiferous tubule of testis—hypothyroidism	0.0107	0.096	CbGeAlD
Levonorgestrel—AR—seminiferous tubule of testis—hypothyroidism	0.00944	0.085	CbGeAlD
Levonorgestrel—SRD5A1—Androgen biosynthesis—POMC—hypothyroidism	0.00463	0.0879	CbGpPWpGaD
Levonorgestrel—Muscle twitching—Liothyronine—hypothyroidism	0.0043	0.0425	CcSEcCtD
Levonorgestrel—Menstruation irregular—Levothyroxine—hypothyroidism	0.00374	0.037	CcSEcCtD
Levonorgestrel—Menstruation irregular—Dextrothyroxine—hypothyroidism	0.00374	0.037	CcSEcCtD
Levonorgestrel—PGR—Nuclear Receptors—THRA—hypothyroidism	0.00334	0.0633	CbGpPWpGaD
Levonorgestrel—Abdominal bloating—Liotrix—hypothyroidism	0.0032	0.0317	CcSEcCtD
Levonorgestrel—SRD5A1—gonad—hypothyroidism	0.00306	0.0275	CbGeAlD
Levonorgestrel—Menstruation irregular—Liotrix—hypothyroidism	0.00275	0.0272	CcSEcCtD
Levonorgestrel—SRD5A1—adrenal gland—hypothyroidism	0.00267	0.024	CbGeAlD
Levonorgestrel—PGR—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00264	0.05	CbGpPWpGaD
Levonorgestrel—AR—Nongenotropic Androgen signaling—SHBG—hypothyroidism	0.00255	0.0483	CbGpPWpGaD
Levonorgestrel—AR—Nuclear Receptors—THRA—hypothyroidism	0.00254	0.0482	CbGpPWpGaD
Levonorgestrel—SRD5A1—testis—hypothyroidism	0.00221	0.0198	CbGeAlD
Levonorgestrel—PGR—Nuclear Receptors—THRB—hypothyroidism	0.00215	0.0408	CbGpPWpGaD
Levonorgestrel—SRD5A1—liver—hypothyroidism	0.00208	0.0188	CbGeAlD
Levonorgestrel—AR—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00201	0.0381	CbGpPWpGaD
Levonorgestrel—CYP3A4—urine—hypothyroidism	0.002	0.018	CbGeAlD
Levonorgestrel—ESR1—Nuclear Receptors—THRA—hypothyroidism	0.00196	0.0372	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of steroid hormones and vitamin D—POMC—hypothyroidism	0.00192	0.0365	CbGpPWpGaD
Levonorgestrel—Arrhythmia—Liothyronine—hypothyroidism	0.00189	0.0187	CcSEcCtD
Levonorgestrel—Tenderness—Liotrix—hypothyroidism	0.00175	0.0173	CcSEcCtD
Levonorgestrel—PGR—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.0017	0.0322	CbGpPWpGaD
Levonorgestrel—AR—Nuclear Receptors—THRB—hypothyroidism	0.00164	0.0311	CbGpPWpGaD
Levonorgestrel—Increased appetite—Levothyroxine—hypothyroidism	0.0016	0.0158	CcSEcCtD
Levonorgestrel—Increased appetite—Dextrothyroxine—hypothyroidism	0.0016	0.0158	CcSEcCtD
Levonorgestrel—Hypertension—Liothyronine—hypothyroidism	0.00159	0.0157	CcSEcCtD
Levonorgestrel—Muscle twitching—Liotrix—hypothyroidism	0.00155	0.0154	CcSEcCtD
Levonorgestrel—ESR1—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00155	0.0294	CbGpPWpGaD
Levonorgestrel—Affect lability—Dextrothyroxine—hypothyroidism	0.00148	0.0146	CcSEcCtD
Levonorgestrel—Affect lability—Levothyroxine—hypothyroidism	0.00148	0.0146	CcSEcCtD
Levonorgestrel—Fluid retention—Liotrix—hypothyroidism	0.00145	0.0143	CcSEcCtD
Levonorgestrel—Mood swings—Levothyroxine—hypothyroidism	0.00142	0.0141	CcSEcCtD
Levonorgestrel—Mood swings—Dextrothyroxine—hypothyroidism	0.00142	0.0141	CcSEcCtD
Levonorgestrel—Lightheadedness—Liotrix—hypothyroidism	0.00136	0.0135	CcSEcCtD
Levonorgestrel—AR—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.0013	0.0246	CbGpPWpGaD
Levonorgestrel—Sweating increased—Levothyroxine—hypothyroidism	0.00127	0.0125	CcSEcCtD
Levonorgestrel—Sweating increased—Dextrothyroxine—hypothyroidism	0.00127	0.0125	CcSEcCtD
Levonorgestrel—Desogestrel—SHBG—hypothyroidism	0.00126	0.219	CrCbGaD
Levonorgestrel—ESR1—Nuclear Receptors—THRB—hypothyroidism	0.00126	0.0239	CbGpPWpGaD
Levonorgestrel—SHBG—cardiovascular system—hypothyroidism	0.00123	0.011	CbGeAlD
Levonorgestrel—Body temperature increased—Liothyronine—hypothyroidism	0.00119	0.0118	CcSEcCtD
Levonorgestrel—Increased appetite—Liotrix—hypothyroidism	0.00118	0.0116	CcSEcCtD
Levonorgestrel—Weight decreased—Dextrothyroxine—hypothyroidism	0.00118	0.0116	CcSEcCtD
Levonorgestrel—Weight decreased—Levothyroxine—hypothyroidism	0.00118	0.0116	CcSEcCtD
Levonorgestrel—PGR—heart—hypothyroidism	0.00117	0.0105	CbGeAlD
Levonorgestrel—SHBG—gonad—hypothyroidism	0.00111	0.01	CbGeAlD
Levonorgestrel—PGR—cardiovascular system—hypothyroidism	0.00111	0.00995	CbGeAlD
Levonorgestrel—Affect lability—Liotrix—hypothyroidism	0.00109	0.0108	CcSEcCtD
Levonorgestrel—SHBG—pituitary gland—hypothyroidism	0.00109	0.00978	CbGeAlD
Levonorgestrel—Mood swings—Liotrix—hypothyroidism	0.00105	0.0104	CcSEcCtD
Levonorgestrel—Etonogestrel—SHBG—hypothyroidism	0.00102	0.177	CrCbGaD
Levonorgestrel—ESR1—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.000998	0.0189	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—NKX2-5—hypothyroidism	0.000989	0.0188	CbGpPWpGaD
Levonorgestrel—PGR—pituitary gland—hypothyroidism	0.000979	0.00881	CbGeAlD
Levonorgestrel—SHBG—adrenal gland—hypothyroidism	0.000971	0.00874	CbGeAlD
Levonorgestrel—SHBG—blood—hypothyroidism	0.000971	0.00874	CbGeAlD
Levonorgestrel—AR—adrenal cortex—hypothyroidism	0.000965	0.00869	CbGeAlD
Levonorgestrel—Abdominal distension—Liotrix—hypothyroidism	0.000962	0.00952	CcSEcCtD
Levonorgestrel—PGR—Nuclear signaling by ERBB4—PRL—hypothyroidism	0.000941	0.0179	CbGpPWpGaD
Levonorgestrel—SHBG—thyroid gland—hypothyroidism	0.000937	0.00843	CbGeAlD
Levonorgestrel—AR—heart—hypothyroidism	0.000934	0.0084	CbGeAlD
Levonorgestrel—Sweating increased—Liotrix—hypothyroidism	0.000931	0.00921	CcSEcCtD
Levonorgestrel—Arrhythmia—Dextrothyroxine—hypothyroidism	0.000929	0.00919	CcSEcCtD
Levonorgestrel—Arrhythmia—Levothyroxine—hypothyroidism	0.000929	0.00919	CcSEcCtD
Levonorgestrel—Bronchitis—Liotrix—hypothyroidism	0.000919	0.0091	CcSEcCtD
Levonorgestrel—Alopecia—Dextrothyroxine—hypothyroidism	0.000919	0.00909	CcSEcCtD
Levonorgestrel—Alopecia—Levothyroxine—hypothyroidism	0.000919	0.00909	CcSEcCtD
Levonorgestrel—ESR1—heart—hypothyroidism	0.000916	0.00825	CbGeAlD
Levonorgestrel—SHBG—female gonad—hypothyroidism	0.000905	0.00815	CbGeAlD
Levonorgestrel—CYP19A1—gonad—hypothyroidism	0.000903	0.00813	CbGeAlD
Levonorgestrel—Tension—Dextrothyroxine—hypothyroidism	0.000889	0.00879	CcSEcCtD
Levonorgestrel—Tension—Levothyroxine—hypothyroidism	0.000889	0.00879	CcSEcCtD
Levonorgestrel—AR—cardiovascular system—hypothyroidism	0.000881	0.00793	CbGeAlD
Levonorgestrel—Nervousness—Levothyroxine—hypothyroidism	0.00088	0.0087	CcSEcCtD
Levonorgestrel—Nervousness—Dextrothyroxine—hypothyroidism	0.00088	0.0087	CcSEcCtD
Levonorgestrel—PGR—adrenal gland—hypothyroidism	0.000875	0.00787	CbGeAlD
Levonorgestrel—PGR—blood—hypothyroidism	0.000874	0.00787	CbGeAlD
Levonorgestrel—Weight decreased—Liotrix—hypothyroidism	0.000865	0.00856	CcSEcCtD
Levonorgestrel—ESR1—cardiovascular system—hypothyroidism	0.000865	0.00778	CbGeAlD
Levonorgestrel—PGR—thyroid gland—hypothyroidism	0.000844	0.0076	CbGeAlD
Levonorgestrel—AR—Notch-mediated HES/HEY network—BGLAP—hypothyroidism	0.000838	0.0159	CbGpPWpGaD
Levonorgestrel—Angioedema—Dextrothyroxine—hypothyroidism	0.000828	0.00819	CcSEcCtD
Levonorgestrel—Angioedema—Levothyroxine—hypothyroidism	0.000828	0.00819	CcSEcCtD
Levonorgestrel—AR—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.000822	0.0156	CbGpPWpGaD
Levonorgestrel—PGR—female gonad—hypothyroidism	0.000815	0.00734	CbGeAlD
Levonorgestrel—SHBG—testis—hypothyroidism	0.000803	0.00723	CbGeAlD
Levonorgestrel—Palpitations—Dextrothyroxine—hypothyroidism	0.0008	0.00792	CcSEcCtD
Levonorgestrel—Palpitations—Levothyroxine—hypothyroidism	0.0008	0.00792	CcSEcCtD
Levonorgestrel—AR—gonad—hypothyroidism	0.000799	0.0072	CbGeAlD
Levonorgestrel—CYP19A1—adrenal gland—hypothyroidism	0.000787	0.00708	CbGeAlD
Levonorgestrel—CYP19A1—blood—hypothyroidism	0.000787	0.00708	CbGeAlD
Levonorgestrel—ESR1—gonad—hypothyroidism	0.000785	0.00706	CbGeAlD
Levonorgestrel—AR—pituitary gland—hypothyroidism	0.00078	0.00702	CbGeAlD
Levonorgestrel—Anxiety—Dextrothyroxine—hypothyroidism	0.000768	0.0076	CcSEcCtD
Levonorgestrel—Anxiety—Levothyroxine—hypothyroidism	0.000768	0.0076	CcSEcCtD
Levonorgestrel—ESR1—pituitary gland—hypothyroidism	0.000766	0.00689	CbGeAlD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—NKX2-5—hypothyroidism	0.000762	0.0145	CbGpPWpGaD
Levonorgestrel—Hypoaesthesia—Liotrix—hypothyroidism	0.000761	0.00753	CcSEcCtD
Levonorgestrel—CYP19A1—thyroid gland—hypothyroidism	0.000759	0.00684	CbGeAlD
Levonorgestrel—SHBG—liver—hypothyroidism	0.000759	0.00683	CbGeAlD
Levonorgestrel—SHBG—cerebellum—hypothyroidism	0.000742	0.00667	CbGeAlD
Levonorgestrel—CYP19A1—female gonad—hypothyroidism	0.000734	0.00661	CbGeAlD
Levonorgestrel—Shock—Levothyroxine—hypothyroidism	0.000727	0.00719	CcSEcCtD
Levonorgestrel—Shock—Dextrothyroxine—hypothyroidism	0.000727	0.00719	CcSEcCtD
Levonorgestrel—PGR—testis—hypothyroidism	0.000723	0.00651	CbGeAlD
Levonorgestrel—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.000715	0.00707	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Levothyroxine—hypothyroidism	0.000715	0.00707	CcSEcCtD
Levonorgestrel—PGR—Generic Transcription Pathway—ZNF764—hypothyroidism	0.000707	0.0134	CbGpPWpGaD
Levonorgestrel—AR—adrenal gland—hypothyroidism	0.000697	0.00627	CbGeAlD
Levonorgestrel—AR—blood—hypothyroidism	0.000697	0.00627	CbGeAlD
Levonorgestrel—ESR1—adrenal gland—hypothyroidism	0.000684	0.00616	CbGeAlD
Levonorgestrel—ESR1—blood—hypothyroidism	0.000684	0.00616	CbGeAlD
Levonorgestrel—Arrhythmia—Liotrix—hypothyroidism	0.000684	0.00676	CcSEcCtD
Levonorgestrel—Alopecia—Liotrix—hypothyroidism	0.000676	0.00669	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.000673	0.00666	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.000673	0.00666	CcSEcCtD
Levonorgestrel—AR—thyroid gland—hypothyroidism	0.000672	0.00605	CbGeAlD
Levonorgestrel—Insomnia—Dextrothyroxine—hypothyroidism	0.000668	0.00661	CcSEcCtD
Levonorgestrel—Insomnia—Levothyroxine—hypothyroidism	0.000668	0.00661	CcSEcCtD
Levonorgestrel—PGR—cerebellum—hypothyroidism	0.000668	0.00601	CbGeAlD
Levonorgestrel—ESR1—thyroid gland—hypothyroidism	0.00066	0.00594	CbGeAlD
Levonorgestrel—Danazol—SHBG—hypothyroidism	0.000659	0.114	CrCbGaD
Levonorgestrel—Dyspnoea—Levothyroxine—hypothyroidism	0.000659	0.00652	CcSEcCtD
Levonorgestrel—Dyspnoea—Dextrothyroxine—hypothyroidism	0.000659	0.00652	CcSEcCtD
Levonorgestrel—Flatulence—Liotrix—hypothyroidism	0.000656	0.00649	CcSEcCtD
Levonorgestrel—Tension—Liotrix—hypothyroidism	0.000654	0.00647	CcSEcCtD
Levonorgestrel—CYP19A1—testis—hypothyroidism	0.000651	0.00586	CbGeAlD
Levonorgestrel—AR—female gonad—hypothyroidism	0.00065	0.00585	CbGeAlD
Levonorgestrel—Nervousness—Liotrix—hypothyroidism	0.000647	0.0064	CcSEcCtD
Levonorgestrel—ESR1—female gonad—hypothyroidism	0.000638	0.00574	CbGeAlD
Levonorgestrel—Fatigue—Dextrothyroxine—hypothyroidism	0.000637	0.0063	CcSEcCtD
Levonorgestrel—Fatigue—Levothyroxine—hypothyroidism	0.000637	0.0063	CcSEcCtD
Levonorgestrel—PGR—Validated nuclear estrogen receptor alpha network—PRL—hypothyroidism	0.000633	0.012	CbGpPWpGaD
Levonorgestrel—CYP19A1—liver—hypothyroidism	0.000615	0.00554	CbGeAlD
Levonorgestrel—Ethinyl Estradiol—SHBG—hypothyroidism	0.00061	0.105	CrCbGaD
Levonorgestrel—Angioedema—Liotrix—hypothyroidism	0.000609	0.00602	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—IYD—hypothyroidism	0.000606	0.0115	CbGpPWpGaD
Levonorgestrel—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000604	0.00598	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000604	0.00598	CcSEcCtD
Levonorgestrel—Syncope—Liotrix—hypothyroidism	0.000597	0.00591	CcSEcCtD
Levonorgestrel—Palpitations—Liotrix—hypothyroidism	0.000589	0.00582	CcSEcCtD
Levonorgestrel—Urticaria—Dextrothyroxine—hypothyroidism	0.000587	0.00581	CcSEcCtD
Levonorgestrel—Urticaria—Levothyroxine—hypothyroidism	0.000587	0.00581	CcSEcCtD
Levonorgestrel—Norethindrone—SHBG—hypothyroidism	0.000587	0.101	CrCbGaD
Levonorgestrel—Loss of consciousness—Liotrix—hypothyroidism	0.000585	0.00579	CcSEcCtD
Levonorgestrel—Abdominal pain—Levothyroxine—hypothyroidism	0.000584	0.00578	CcSEcCtD
Levonorgestrel—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000584	0.00578	CcSEcCtD
Levonorgestrel—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000584	0.00578	CcSEcCtD
Levonorgestrel—Body temperature increased—Levothyroxine—hypothyroidism	0.000584	0.00578	CcSEcCtD
Levonorgestrel—AR—testis—hypothyroidism	0.000576	0.00519	CbGeAlD
Levonorgestrel—Hypertension—Liotrix—hypothyroidism	0.000575	0.00569	CcSEcCtD
Levonorgestrel—Chest pain—Liotrix—hypothyroidism	0.000567	0.00561	CcSEcCtD
Levonorgestrel—ESR1—testis—hypothyroidism	0.000566	0.00509	CbGeAlD
Levonorgestrel—Anxiety—Liotrix—hypothyroidism	0.000565	0.00559	CcSEcCtD
Levonorgestrel—CYP19A1—Endogenous sterols—POMC—hypothyroidism	0.000558	0.0106	CbGpPWpGaD
Levonorgestrel—Methyltestosterone—SHBG—hypothyroidism	0.000557	0.0963	CrCbGaD
Levonorgestrel—ESR1—Nuclear signaling by ERBB4—PRL—hypothyroidism	0.000553	0.0105	CbGpPWpGaD
Levonorgestrel—AR—liver—hypothyroidism	0.000545	0.0049	CbGeAlD
Levonorgestrel—Oedema—Liotrix—hypothyroidism	0.000544	0.00538	CcSEcCtD
Levonorgestrel—Infection—Liotrix—hypothyroidism	0.00054	0.00534	CcSEcCtD
Levonorgestrel—AR—Generic Transcription Pathway—ZNF764—hypothyroidism	0.000539	0.0102	CbGpPWpGaD
Levonorgestrel—Shock—Liotrix—hypothyroidism	0.000535	0.00529	CcSEcCtD
Levonorgestrel—ESR1—liver—hypothyroidism	0.000535	0.00481	CbGeAlD
Levonorgestrel—Asthenia—Dextrothyroxine—hypothyroidism	0.00053	0.00525	CcSEcCtD
Levonorgestrel—Asthenia—Levothyroxine—hypothyroidism	0.00053	0.00525	CcSEcCtD
Levonorgestrel—AR—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00053	0.01	CbGpPWpGaD
Levonorgestrel—Hyperhidrosis—Liotrix—hypothyroidism	0.000526	0.0052	CcSEcCtD
Levonorgestrel—Pruritus—Dextrothyroxine—hypothyroidism	0.000523	0.00517	CcSEcCtD
Levonorgestrel—Pruritus—Levothyroxine—hypothyroidism	0.000523	0.00517	CcSEcCtD
Levonorgestrel—ESR1—cerebellum—hypothyroidism	0.000522	0.0047	CbGeAlD
Levonorgestrel—Anorexia—Liotrix—hypothyroidism	0.000518	0.00513	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—ATP5O—hypothyroidism	0.000515	0.00977	CbGpPWpGaD
Levonorgestrel—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000506	0.005	CcSEcCtD
Levonorgestrel—Diarrhoea—Levothyroxine—hypothyroidism	0.000506	0.005	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000495	0.0049	CcSEcCtD
Levonorgestrel—Insomnia—Liotrix—hypothyroidism	0.000492	0.00486	CcSEcCtD
Levonorgestrel—Dyspnoea—Liotrix—hypothyroidism	0.000485	0.00479	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—TPO—hypothyroidism	0.000484	0.00918	CbGpPWpGaD
Levonorgestrel—Decreased appetite—Liotrix—hypothyroidism	0.000473	0.00468	CcSEcCtD
Levonorgestrel—Vomiting—Levothyroxine—hypothyroidism	0.00047	0.00465	CcSEcCtD
Levonorgestrel—Vomiting—Dextrothyroxine—hypothyroidism	0.00047	0.00465	CcSEcCtD
Levonorgestrel—Fatigue—Liotrix—hypothyroidism	0.000469	0.00464	CcSEcCtD
Levonorgestrel—Rash—Dextrothyroxine—hypothyroidism	0.000466	0.00461	CcSEcCtD
Levonorgestrel—Rash—Levothyroxine—hypothyroidism	0.000466	0.00461	CcSEcCtD
Levonorgestrel—Dermatitis—Dextrothyroxine—hypothyroidism	0.000466	0.00461	CcSEcCtD
Levonorgestrel—Dermatitis—Levothyroxine—hypothyroidism	0.000466	0.00461	CcSEcCtD
Levonorgestrel—Constipation—Liotrix—hypothyroidism	0.000465	0.0046	CcSEcCtD
Levonorgestrel—AR—Coregulation of Androgen receptor activity—VAV3—hypothyroidism	0.000464	0.0088	CbGpPWpGaD
Levonorgestrel—Headache—Dextrothyroxine—hypothyroidism	0.000463	0.00458	CcSEcCtD
Levonorgestrel—Headache—Levothyroxine—hypothyroidism	0.000463	0.00458	CcSEcCtD
Levonorgestrel—PGR—Generic Transcription Pathway—THRA—hypothyroidism	0.000456	0.00864	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000449	0.00851	CbGpPWpGaD
Levonorgestrel—Gastrointestinal pain—Liotrix—hypothyroidism	0.000445	0.0044	CcSEcCtD
Levonorgestrel—Nausea—Dextrothyroxine—hypothyroidism	0.000439	0.00434	CcSEcCtD
Levonorgestrel—Nausea—Levothyroxine—hypothyroidism	0.000439	0.00434	CcSEcCtD
Levonorgestrel—Urticaria—Liotrix—hypothyroidism	0.000432	0.00427	CcSEcCtD
Levonorgestrel—Abdominal pain—Liotrix—hypothyroidism	0.00043	0.00425	CcSEcCtD
Levonorgestrel—Body temperature increased—Liotrix—hypothyroidism	0.00043	0.00425	CcSEcCtD
Levonorgestrel—Hydrocortisone—SHBG—hypothyroidism	0.00042	0.0725	CrCbGaD
Levonorgestrel—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—hypothyroidism	0.000418	0.00792	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—ZNF764—hypothyroidism	0.000415	0.00787	CbGpPWpGaD
Levonorgestrel—Hypersensitivity—Liotrix—hypothyroidism	0.000401	0.00396	CcSEcCtD
Levonorgestrel—Asthenia—Liotrix—hypothyroidism	0.00039	0.00386	CcSEcCtD
Levonorgestrel—Pruritus—Liotrix—hypothyroidism	0.000385	0.0038	CcSEcCtD
Levonorgestrel—CYP3A4—blood—hypothyroidism	0.000382	0.00343	CbGeAlD
Levonorgestrel—Diarrhoea—Liotrix—hypothyroidism	0.000372	0.00368	CcSEcCtD
Levonorgestrel—ESR1—Validated nuclear estrogen receptor alpha network—PRL—hypothyroidism	0.000372	0.00705	CbGpPWpGaD
Levonorgestrel—Dizziness—Liotrix—hypothyroidism	0.00036	0.00356	CcSEcCtD
Levonorgestrel—AR—Generic Transcription Pathway—THRA—hypothyroidism	0.000347	0.00659	CbGpPWpGaD
Levonorgestrel—Vomiting—Liotrix—hypothyroidism	0.000346	0.00342	CcSEcCtD
Levonorgestrel—Rash—Liotrix—hypothyroidism	0.000343	0.00339	CcSEcCtD
Levonorgestrel—Dermatitis—Liotrix—hypothyroidism	0.000342	0.00339	CcSEcCtD
Levonorgestrel—Progesterone—SHBG—hypothyroidism	0.000342	0.0591	CrCbGaD
Levonorgestrel—Headache—Liotrix—hypothyroidism	0.000341	0.00337	CcSEcCtD
Levonorgestrel—PGR—Gene Expression—ZNF764—hypothyroidism	0.000341	0.00646	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000325	0.00616	CbGpPWpGaD
Levonorgestrel—Testosterone—SHBG—hypothyroidism	0.000323	0.0559	CrCbGaD
Levonorgestrel—Nausea—Liotrix—hypothyroidism	0.000323	0.00319	CcSEcCtD
Levonorgestrel—PGR—Signaling by ERBB4—PRL—hypothyroidism	0.000317	0.00601	CbGpPWpGaD
Levonorgestrel—ESR1—Plasma membrane estrogen receptor signaling—IGF1—hypothyroidism	0.000302	0.00574	CbGpPWpGaD
Levonorgestrel—CYP3A4—liver—hypothyroidism	0.000298	0.00269	CbGeAlD
Levonorgestrel—PGR—Generic Transcription Pathway—THRB—hypothyroidism	0.000294	0.00557	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—THRA—hypothyroidism	0.000268	0.00507	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—ZNF764—hypothyroidism	0.000259	0.00492	CbGpPWpGaD
Levonorgestrel—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000259	0.00491	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000247	0.00469	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—TSHB—hypothyroidism	0.000224	0.00425	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—THRB—hypothyroidism	0.000224	0.00424	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—THRA—hypothyroidism	0.000219	0.00416	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000211	0.004	CbGpPWpGaD
Levonorgestrel—CYP19A1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00021	0.00398	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—ZNF764—hypothyroidism	0.0002	0.00379	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PIK3C2A—hypothyroidism	0.0002	0.00379	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000197	0.00374	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000191	0.00361	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—PRL—hypothyroidism	0.000186	0.00353	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—THRB—hypothyroidism	0.000172	0.00327	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—SLC5A5—hypothyroidism	0.000168	0.00318	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—THRA—hypothyroidism	0.000167	0.00317	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—NKX2-5—hypothyroidism	0.000156	0.00297	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—THRB—hypothyroidism	0.000141	0.00268	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—IYD—hypothyroidism	0.000132	0.00249	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—THRA—hypothyroidism	0.000129	0.00244	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—NKX2-5—hypothyroidism	0.000119	0.00226	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000115	0.00217	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ATP5O—hypothyroidism	0.000112	0.00212	CbGpPWpGaD
Levonorgestrel—CYP19A1—Biological oxidations—POMC—hypothyroidism	0.000112	0.00211	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—THRB—hypothyroidism	0.000108	0.00204	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—TPO—hypothyroidism	0.000105	0.00199	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	9.75e-05	0.00185	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NKX2-5—hypothyroidism	9.18e-05	0.00174	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	8.83e-05	0.00167	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—POMC—hypothyroidism	8.78e-05	0.00167	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—THRB—hypothyroidism	8.3e-05	0.00157	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CLTC—hypothyroidism	8.06e-05	0.00153	CbGpPWpGaD
Levonorgestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	7.56e-05	0.00143	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TRH—hypothyroidism	6.97e-05	0.00132	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TSHB—hypothyroidism	6.21e-05	0.00118	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TSHR—hypothyroidism	6.21e-05	0.00118	CbGpPWpGaD
Levonorgestrel—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	6.13e-05	0.00116	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SH2B3—hypothyroidism	5.54e-05	0.00105	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—TSHB—hypothyroidism	4.87e-05	0.000923	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CLTC—hypothyroidism	4.73e-05	0.000897	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3C2A—hypothyroidism	4.34e-05	0.000823	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.28e-05	0.000812	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PRL—hypothyroidism	4.11e-05	0.000779	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TRH—hypothyroidism	4.09e-05	0.000776	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—IYD—hypothyroidism	3.84e-05	0.000728	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—VAV3—hypothyroidism	3.8e-05	0.00072	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AVP—hypothyroidism	3.66e-05	0.000694	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—SLC5A5—hypothyroidism	3.65e-05	0.000691	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TSHB—hypothyroidism	3.65e-05	0.000691	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TSHR—hypothyroidism	3.65e-05	0.000691	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ATP5O—hypothyroidism	3.26e-05	0.000619	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—POMC—hypothyroidism	3.25e-05	0.000617	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SH2B3—hypothyroidism	3.25e-05	0.000616	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—TPO—hypothyroidism	3.07e-05	0.000582	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—POMC—hypothyroidism	2.43e-05	0.000461	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PRL—hypothyroidism	2.41e-05	0.000457	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IGF1—hypothyroidism	2.34e-05	0.000444	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—VAV3—hypothyroidism	2.23e-05	0.000423	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AVP—hypothyroidism	2.15e-05	0.000407	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—POMC—hypothyroidism	1.91e-05	0.000362	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—POMC—hypothyroidism	1.43e-05	0.000271	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—TSHB—hypothyroidism	1.42e-05	0.000269	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IGF1—hypothyroidism	1.37e-05	0.00026	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	1.27e-05	0.00024	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.06e-05	0.000202	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—POMC—hypothyroidism	5.57e-06	0.000106	CbGpPWpGaD
